Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

43
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Firearm Violence Exposure in Primary Care Clinical Notes: Protocol for Developing a National Language Processing Text Classifier.

JMIR research protocols·2025
Same author

Engaging Stakeholders With Professional or Lived Experience to Improve Firearm Violence Lexicon Development.

JMIR formative research·2025
Same author

An Efficient, Lightweight, Tiny 2D-CNN Ensemble Model to Detect Cardiomegaly in Heart CT Images.

Journal of personalized medicine·2023
Same journal

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1993.

Journal of personalized medicine·2026
Same journal

Correction: Rao et al. Ensemble Deep-Learning-Based Prognostic and Prediction for Recurrence of Sporadic Odontogenic Keratocysts on Hematoxylin and Eosin Stained Pathological Images of Incisional Biopsies. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1220.

Journal of personalized medicine·2026
Same journal

Three-Dimensional Bronchovascular Modelling in Sublobar Pulmonary Resection: A Tool for Personalised Thoracic Surgery.

Journal of personalized medicine·2026
Same journal

Serum Albumin, Globulin and Albumin-Globulin Ratios as Biomarkers of Clinical Outcomes in COVID-19 Pneumonia.

Journal of personalized medicine·2026
Same journal

New Advances and Perspectives in Ophthalmology: Progress and Modern Challenges Toward Personalized Eye Care.

Journal of personalized medicine·2026
Same journal

Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine.

Journal of personalized medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 3, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

MLP-PSO Hybrid Algorithm for Heart Disease Prediction.

Ali Al Bataineh1, Sarah Manacek2

  • 1Department of Electrical and Computer Engineering, Norwich University, Barre, VT 05663, USA.

Journal of Personalized Medicine
|July 27, 2022
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) models can predict heart disease risk. A new hybrid ML approach, MLP-PSO, achieved 84.61% accuracy, enabling earlier and more effective cardiovascular disease diagnosis.

Keywords:
MLPPSOheart disease predictionmachine learningneural networks

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

13.8K

Related Experiment Videos

Last Updated: Sep 3, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations
12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

13.8K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Machine learning (ML) is increasingly vital in healthcare for enhancing diagnostic accuracy and timeliness.
  • Predicting and preventing cardiovascular disease (CVD) is a critical area in clinical data analysis due to rising treatment costs.
  • Manual assessment of heart disease risk is challenging due to numerous contributing factors.

Purpose of the Study:

  • To develop and compare ML algorithms for predicting heart disease using the Cleveland Heart Disease dataset.
  • To introduce and evaluate an alternative multilayer perceptron (MLP) training technique using particle swarm optimization (PSO) for heart disease detection.

Main Methods:

  • The study employed a proposed MLP-PSO hybrid algorithm alongside ten other ML algorithms.
  • Performance evaluation was conducted using various classification metrics.

Main Results:

  • The proposed MLP-PSO hybrid algorithm demonstrated superior performance compared to all other tested algorithms.
  • The MLP-PSO model achieved an accuracy of 84.61% in predicting heart disease.

Conclusions:

  • The developed MLP-PSO classifier facilitates earlier, more accurate, and effective diagnosis of heart disease.
  • This ML-based approach empowers healthcare providers with better tools for cardiovascular disease management.